Bayer Sells Nebido To Grünenthal Amid Shift In Focus To Cell And Gene Pipeline

Will Sell For Up To €500m

 
• By Ayisha Sharma
  
The Divestment Will Generate Funds To Invest In Innovative New Therapies • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business